In this study, the proportion of CD4+ T cells remained stable in model mice, while that of CD8+ T cells was increased by PD-L1 inhibitor and inhibited by CircCHST15 in the mouse tumor, and PD-L1 inhibitor reversed the effect of CircCHST15. This evidence concerns the gene CD4 and neoplasm.